APOE and Alzheimer disease: Genetic predispositions that impair this mechanism in favor of the synapse-suppressing Aβ, such as ApoE4 genotype and mutations in APP or the presenilins, which release Aβ from APP, lead to an imbalance of Aβ levels and initiate AD pathogenesis.